PRELIMINARY
PROGRAM
Invited Speakers Preliminary Program
**Click on the drop down of topic to view discussions
- Cardio Obstetrics
- Risk Prediction and Mortality
- Cardiac Evaluation and Imaging
- Valvular Heart Disease and Pregnancy
- Congenital Heart Disease and Pregnancy
-
Infertility and Contraceptives in
Women with Cardiac Disease, IVF - Arrhythmias and Pregnancy
- Peripartum Cardiomyopathy
- Cardiomyopathy, Myocarditis Heart Failure and Pericardial Disease
- Vascular Disease in Pregnancy
- Management during Labor and Delivery
- Hypertension and Preeclampsia
- Coronary Artery Disease
- Pregnancy with Medical Problems
- Pulmonary HTN and VTE in Pregnancy
- Registries
- Biomarkers
- Drugs in Pregnancy
- Resuscitation in Pregnancy
Cardio Obstetrics |
Cardio-Obstetrics: Lessons that I have Learn over 3 Decades
|
Evolving Strategies for Improving the Consistency of Care in Cardiac Patient during Pregnancy
|
Getting your Cardio Obstetrics Papers Published: Perspectives from an Editor
|
Training in Cardio-Obstetrics: Challenges and Opportunities for Subspecialty Training
|
Cardiovascular Care for Pregnant Women with Cardiovascular Disease – 306 Patients the Columbia University New York Experience
|
4th Trimester- What is the Care Model for Optimizing Postpartum Cardiovascular Heath Outcome
|
Optimizing the Inclusion of Pregnant Individuals in Prospective Cohort Studies and Clinical Trials to Advance the Field of Cardio-Obstetrics
|
Developing a National Protocol for Managing Heart Disease—NPAC (National Pregnancy and Cardiac Disease) India Study Methodology
|
Artificial Intelligence-Powered Tools for Cardiac Screening in Obstetric Patients
|
Use of Genetic Testing in the Pregnant Patients with Cardiac Disease
|
Stories from the Joint Gyneco-Cardio Clinic – Does it Improve Outcomes?
|
Risk Prediction and Mortality |
Universal CVD Risk Assessment in Pregnancy: Pros and Cons
|
Risk Prediction: 2025 Update
|
How to Tackle Cardiovascular Disease Related Maternal Morbidity and Mortality?
|
Adverse Pregnancy Outcomes and Long-term Risk of Cardiovascular Disease
|
What Cardiac Diagnoses are the Highest Risk? Is Pregnancy Termination Indicated?
|
Cardiac Evaluation and Imaging |
Exercise and Stress Testing during Pregnancy
|
When Echocardiography should be Used in Pregnancy?
|
Cardiovascular Adaptation in Normal Pregnancy
|
Cardiac POCUS on Labor and Delivery
|
Lung POCUS on Labor and Delivery
|
Valvular Heart Disease and Pregnancy |
Mechanical Valve and Pregnancy – the ROPAC Experience
|
Updating the Risk Stratification Systems in Valvular Heart Disease: The Way Forward
|
Prosthetic Heart Valve Thrombosis and the Challenges in Bridging Anticoagulation
|
Managing Stenotic Lesions in Pregnancy – Antenatal Valve Interventions, When and how?
|
Heparin in Pregnancy: Trimester Effects and Dosing Design to Meet Guidelines
|
Factors Affecting Anticoagulant Choices for Pregnant Patients with Mechanical Heart Valves Across High and Low-Resource Settings: An International Qualitative Research Study
|
The Optimal Monitoring Regimen for LMWH in Pregnant Persons with MHVs.
|
TAVR in Pregnancy: Advantages and Limitations
|
Congenital Heart Disease and Pregnancy |
Management of the Patient with Fontan Circulation during Pregnancy
|
Ebstein’s Anomaly and Pregnancy Management
|
Bicuspid Aortic Valve and Pregnancy
|
Systemic Right Ventricles and Considerations in Pregnancy
|
Pregnancy in Post Tetralogy of Fallot Repair
|
Eisenmenger Syndrome and Pregnancy
|
Maternal and Fetal Outcome of Pregnancy in Women with D-Transposition and Congenitally Corrected Transposition of the Great Vessels
|
Simplifying Congenital Heart Disease during Pregnancy
|
Infertility and Contraceptives in Women with Cardiac Disease, IVF |
Fertility Therapy Considerations in Women with Cardiac Disease
|
Infertility Success in Women over 40 Years of Age
|
Contraception for the Cardiac Patient
|
Understanding the 2024 US Medical Eligibility Criteria for Contraceptive Use
|
Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology
|
Arrhythmias and Pregnancy |
Genetic Arrhythmias in Pregnancy (LQT, ARVC, etc)
|
Dysautonomia in Pregnancy
|
Advancing our Understanding of Pregnancy-Associated Atrial Fibrillation
|
Contemporary Approach to Ablation during Pregnancy
|
Management of Electrophysiological Devices in Pregnancy
|
Maternal and Fetal Implications of Transplacental Therapy for Fetal Tachycardia
|
Peripartum Cardiomyopathy |
Living with PPCM: The Patient Perspective
|
Mental Health in PPCM
|
The REBIRTH Study – Status Report
|
The EORP Dataset on Bromocriptine Use
|
Long Term Follow-Up Outcomes in Patients with PPCM
|
PPCM: Socioeconomic Factors Versus Ethnicity
|
Long-term Considerations for Patients with Peripartum Cardiomyopathy (ICD Use, Long-term Adverse Outcomes)
|
Long-term Outcome of Women with Peripartum Cardiomyopathy having Subsequent Pregnancy
|
PPCM and Subsequent Pregnancy: Results of the EHC EORP Registry
|
Geographical Differences in PPCM Presentation over the Globe
|
Cardiomyopathy, Myocarditis Heart Failure and Pericardial Disease |
VV-ECMO and Pregnancy: What’s New?
|
Heart Failure with Preserved Ejection Fraction in Pregnancy
|
Management of Pregnancy after Cardiac Transplantation
|
Peripartum Takotsubo Cardiomyopathy – The Obstetrician’s Perspective
|
Pericarditis in Pregnancy – Obstetric Challenges in the Management of Recurrent Pericarditis in Pregnancy
|
Pregnancy with Severe Hypertrophic Cardiomyopathy – Experience of a Tertiary Center
|
The Risk of Pregnancy in Women with HFrEF
|
Vascular Disease in Pregnancy |
Non-Marfan Aortopathy –Management in Pregnancy
|
Turner Syndrome and Pregnancy
|
The Approach to Pregnancy in Women with Marfan Aortopathy
|
Cardiac Surgery in Patients with Pregnancy Associated Aortic Dissection
|
Delivery for Women with Aortopathy and Pregnancy
|
Management during Labor and Delivery | |
Neuraxial Analgesia for Labor and Delivery in the Patient with Cardiovascular Disease
|
|
Maternal Cardiovascular Monitoring during Labor, Cesarean and the Postpartum
|
|
Normal Hemodynamics of Pregnancy and Delivery
|
|
What Cardiac Diagnoses are the Highest Risk? Is Pregnancy Termination Indicated?
|
|
The Use of Uterotonics in Labor and Delivery – Safety Considerations in the Cardiac Patients
|
|
Labor and Delivery Pharmacology: OB Drugs with CV Implications and CV Drugs with OB Implications
|
|
The Heart of Obstetric Care: Enhancing Antepartum and Labor Management in Cardio-Obstetrics
|
|
Heart Failure Crisis on Labor and Delivery and Hemodynamic Implications of Labor Analgesia
|
|
Critical Care Management of the Pregnant Woman with Cardiac Disease
|
|
Hypertension and Preeclampsia | |
Antepartum and Postpartum Management of Hypertension
|
|
Hypertensive Disease of Pregnancy: Individualization of Pharmacotherapy
|
|
Addressing Pre-Eclampsia Prevention
|
|
Cardiovascular Disease after Preeclampsia: Advances in Mechanism of Action and Clinical Interventions
|
|
Coronary Artery Disease |
Pregnancy Post SCAD: Yes or No
|
Myocardial Bridge in Pregnancy- Case Series and Review
|
Coronary Interventions in Pregnancy: A Word of Caution.
|
Pregnancy with Medical Problems |
Cardiometabolic Health in Pregnancy
|
Lipid in Pregnancy Update
|
Gestational Diabetes and Cardiovascular Disease
|
Risks for Pregnancy at Advanced Maternal Age- Cardiometabolic Risks
|
Addressing Psychological and Cardiovascular Health Across the Perinatal Period
|
Association of Pre-pregnancy Cardiometabolic Factors with Adverse Pregnancy Outcomes
|
Pulmonary HTN and VTE in Pregnancy |
Pulmonary Arterial Hypertension in Pregnancy – What have we Learned Over the Past 2 Decades?
|
Navigating Safe Births: Pregnancy with Pulmonary Hypertension
|
How to Improve the Outcome of Pregnancy in Women with Pulmonary Arterial Hypertension
|
Registries |
A Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): an International, Multi-Methods Consensus Study
|
The HOPE Pilot Results (1 Years NACE, MACE, APOs)
|
The HOPE Registry – Methods and Protocol
|
ROPAC Analysis of Obstetric Outcomes
|
Cardio-obstetric Team Approach- Ensuring Feasibility to Improve Outcome in Developing Nations- Lessons from Tamil Nadu Pregnancy and Heart Disease Registry (TNPHDR is not yet Published. Presented as Late Breaking Science at ESC 2024)
|
Pregnancy and Labor in Women with Heart Diseases. 30 years’ Experience of 800 Pregnancy. The Israel northern registry
|
An Update on the Canadian Network of Networks for Reducing Cardiovascular Mortality and Morbidity in Pregnancy (CaNCaM-Preg)
|
Biomarkers |
Use of Cardiac Biomarkers in Pregnancy
|
Drugs in Pregnancy |
Beta Blocker Use Considerations among Pregnant Women with Cardiac Disease
|
Betablocker use during Pregnancy – The ROPAC Experience |
Pregnancy Outcomes after Cardiotoxic Cancer Therapy
|
Which Cardiovascular Medications Should Not be used during Pregnancy and Lactation and why?
|
Resuscitation in Pregnancy |
Maternal Cardiac Arrest and ECPR
|
Maternal Cardiac Arrest on Labor and Delivery
|